Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports

Fig. 2

Longitudinal observation of branching vascular network and polyp using optical coherence tomography angiography. Nine months before combination therapy of photodynamic therapy (PDT) and intravitreal injection of ranibizumab (IVR), en face optical coherence tomography angiography (OCT-A) reveals the branching vascular network (BVN; between arrowheads) and a polyp (yellow arrow). This eye had previously undergone 33 IVRs (a). After 9 additional IVRs, the BVN and polyp show no apparent regression (b). One week after combination IVR (43rd) and PDT, OCT-A confirms complete regression of the BVN and polyp (c). BVN shows gradual reperfusion at 1 month (d) and 2 months (e). At 3 months, the BVN has restored most of its original network (between arrowheads) while the polyp remains absent (yellow arrow) (f)

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us